Evidence map›Paper›PMID 42885041›Full record

ArticlePolymers2026

mPEG-

Irina Bagaeva, Ekaterina Sinitsyna, Yuliia Zmitrichenko, Gregorii Tochilnikov, Elena Tupikina, Sergei Silonov, Mikhail Orlov, Viktor Korzhikov-Vlakh, Evgenia Korzhikova-Vlakh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Irina BagaevaInstitute of Chemistry, Saint-Petersburg State University, Universitetskiy Pr. 26, 198504 St. Petersburg, Russia.ORCID 0000-0002-6120-3958
Ekaterina SinitsynaBranch of Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Center "Kurchatov Institute"-Institute of Macromolecular Compounds, Bolshoi Pr. 31, 199004 St. Petersburg, Russia.ORCID 0000-0002-0414-1121
Yuliia ZmitrichenkoNMRC Institute of Oncology Named After N.N. Petrov, Leningradskaya Str. 68, Pesochny, 197758 St. Petersburg, Russia.
Gregorii TochilnikovNMRC Institute of Oncology Named After N.N. Petrov, Leningradskaya Str. 68, Pesochny, 197758 St. Petersburg, Russia.
Elena TupikinaInstitute of Chemistry, Saint-Petersburg State University, Universitetskiy Pr. 26, 198504 St. Petersburg, Russia.ORCID 0000-0002-0998-8348
Sergei SilonovInstitute of Chemistry, Saint-Petersburg State University, Universitetskiy Pr. 26, 198504 St. Petersburg, Russia.ORCID 0000-0001-8714-6659
Mikhail OrlovInstitute of Chemistry, Saint-Petersburg State University, Universitetskiy Pr. 26, 198504 St. Petersburg, Russia.ORCID 0009-0000-4810-6400
Viktor Korzhikov-VlakhInstitute of Chemistry, Saint-Petersburg State University, Universitetskiy Pr. 26, 198504 St. Petersburg, Russia.ORCID 0000-0002-3509-3978
Evgenia Korzhikova-VlakhInstitute of Chemistry, Saint-Petersburg State University, Universitetskiy Pr. 26, 198504 St. Petersburg, Russia.ORCID 0000-0002-2530-7709

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing nanoformulations of antitumor drugs represents a critical priority in addressing key challenges of free drug administration such as low therapeutic efficacy, poor bioavailability, and severe side effects, including high systemic toxicity. In this study, mPEG-

Indexed as

antitumor activityaziridine-functionalized triazine derivativedioxadetdrug delivery systemsnanoparticlespoly(ethylene glycol)-b-poly(ε-caprolactone)

Identifiers

PMID42885041
PMCPMC13667229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.